Generated $48.1 million in XDEMVY® net product sales driven by more than 41,400 bottles delivered to patients in the third quarterStrengthened ...

The study is being conducted under a Special Protocol Agreement (SPA) with the U.S. Food and Drug Administration (FDA ... tyrosine kinase inhibitor with anti-angiogenic properties, being evaluated for ...

About TP-05 TP-05 is an oral systemic formulation of lotilaner, a well-characterized anti-parasitic agent that selectively inhibits parasite-specific GABA-Cl channels. TP-05 is believed to be the only ...

Warmer weather is here and so are the mosquitoes. Here’s what happens when a mozzie bites and our body reacts.

There’s been talk of GLP-1 and semaglutide drugs, like Ozempic, causing hair loss ... I like to do Kenalog in very small ...

They will also check that you adhered to the recommended food and drug restrictions. You will then be escorted ... let the ...